Heidi Griesmann

1.0k total citations
20 papers, 650 citations indexed

About

Heidi Griesmann is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Heidi Griesmann has authored 20 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Heidi Griesmann's work include Pancreatic and Hepatic Oncology Research (8 papers), Neuroendocrine Tumor Research Advances (4 papers) and Epigenetics and DNA Methylation (4 papers). Heidi Griesmann is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Neuroendocrine Tumor Research Advances (4 papers) and Epigenetics and DNA Methylation (4 papers). Heidi Griesmann collaborates with scholars based in Germany, United Kingdom and Switzerland. Heidi Griesmann's co-authors include Patrick Michl, Thomas M. Gress, Bence Sipos, Albrecht Neeße, Malte Buchholz, Jonas Rosendahl, Thorsten Stiewe, S Ripka, Michaela Beitzinger and Rasa Beinoravičiūtė-Kellner and has published in prestigious journals such as The EMBO Journal, Cancer Cell and Oncogene.

In The Last Decade

Heidi Griesmann

19 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heidi Griesmann Germany 13 353 333 141 111 75 20 650
Demirkan Gursel United States 19 491 1.4× 270 0.8× 284 2.0× 112 1.0× 74 1.0× 32 970
John J. Halliday United States 7 309 0.9× 231 0.7× 212 1.5× 117 1.1× 67 0.9× 9 731
Nicolas Gengenbacher Germany 8 306 0.9× 194 0.6× 153 1.1× 99 0.9× 22 0.3× 10 629
Véronique Garambois France 15 296 0.8× 306 0.9× 92 0.7× 77 0.7× 29 0.4× 32 775
Hideo Takeshima Japan 13 219 0.6× 166 0.5× 69 0.5× 137 1.2× 49 0.7× 18 512
Ivane Abiatari Georgia 13 460 1.3× 512 1.5× 214 1.5× 146 1.3× 65 0.9× 32 1.0k
Carl Koschmann United States 18 428 1.2× 181 0.5× 249 1.8× 120 1.1× 83 1.1× 79 935
Shobha Castelino‐Prabhu United States 10 486 1.4× 232 0.7× 90 0.6× 86 0.8× 69 0.9× 15 796
Elin Ekström Sweden 5 514 1.5× 227 0.7× 288 2.0× 191 1.7× 27 0.4× 6 810
Rana Mhaidly France 11 285 0.8× 375 1.1× 135 1.0× 314 2.8× 31 0.4× 19 745

Countries citing papers authored by Heidi Griesmann

Since Specialization
Citations

This map shows the geographic impact of Heidi Griesmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi Griesmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi Griesmann more than expected).

Fields of papers citing papers by Heidi Griesmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidi Griesmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi Griesmann. The network helps show where Heidi Griesmann may publish in the future.

Co-authorship network of co-authors of Heidi Griesmann

This figure shows the co-authorship network connecting the top 25 collaborators of Heidi Griesmann. A scholar is included among the top collaborators of Heidi Griesmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi Griesmann. Heidi Griesmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Verma, Atul, Michael Boettcher, Ivonne Regel, et al.. (2025). Hereditary chronic pancreatitis induced plasticity cooperates with mutant Kras in early pancreatic carcinogenesis. Gut. gutjnl–2025.
2.
Griesmann, Heidi, Monika Hämmerle, Helmut Laumen, et al.. (2023). Gender-specific changes of the gut microbiome correlate with tumor development in murine models of pancreatic cancer. iScience. 26(6). 106841–106841. 7 indexed citations
3.
4.
Misiak, Danny, et al.. (2022). IGF2BP1 Promotes Proliferation of Neuroendocrine Neoplasms by Post-Transcriptional Enhancement of EZH2. Cancers. 14(9). 2121–2121. 12 indexed citations
5.
Griesmann, Heidi, Jan Riedel, Bence Sipos, et al.. (2021). CUX1 Enhances Pancreatic Cancer Formation by Synergizing with KRAS and Inducing MEK/ERK-Dependent Proliferation. Cancers. 13(10). 2462–2462. 11 indexed citations
6.
Prisco, Nicola de, Dominik Wiese, Samir Jabari, et al.. (2020). Modulation of Pancreatic Neuroendocrine Neoplastic Cell Fate by Autophagy-Mediated Death. Neuroendocrinology. 111(10). 965–985. 13 indexed citations
7.
Rasch, Sebastian, Sebastian Beer, Rick Schneider, et al.. (2019). Serum levels of advanced glycation end products and their receptors sRAGE and Galectin-3 in chronic pancreatitis. Pancreatology. 20(2). 187–192. 6 indexed citations
8.
Krug, Sebastian, Heidi Griesmann, Bence Sipos, et al.. (2018). Therapeutic targeting of tumor‐associated macrophages in pancreatic neuroendocrine tumors. International Journal of Cancer. 143(7). 1806–1816. 38 indexed citations
9.
Griesmann, Heidi, et al.. (2016). Pharmacological macrophage inhibition decreases metastasis formation in a genetic model of pancreatic cancer. Gut. 66(7). 1278–1285. 104 indexed citations
10.
Kühnemuth, Benjamin, Eithne Costello, Victoria Shaw, et al.. (2016). miRNA dynamics in tumor-infiltrating myeloid cells modulating tumor progression in pancreatic cancer. OncoImmunology. 5(6). e1160181–e1160181. 19 indexed citations
11.
Krug, Sebastian, Benjamin Kühnemuth, Heidi Griesmann, et al.. (2014). CUX1: a modulator of tumour aggressiveness in pancreatic neuroendocrine neoplasms. Endocrine Related Cancer. 21(6). 879–890. 14 indexed citations
12.
Griesmann, Heidi, S Ripka, Volker Ellenrieder, et al.. (2013). WNT5A-NFAT Signaling Mediates Resistance to Apoptosis in Pancreatic Cancer. Neoplasia. 15(1). 11–IN9. 69 indexed citations
13.
Kühnemuth, Benjamin, S Ripka, Heidi Griesmann, et al.. (2013). Synthetic Lethality Screen Identifies RPS6KA2 as Modifier of Epidermal Growth Factor Receptor Activity in Pancreatic Cancer. Neoplasia. 15(12). 1354–1362. 31 indexed citations
14.
Kühnemuth, Benjamin, Heidi Griesmann, Albrecht Neeße, et al.. (2013). CUX1 modulates polarization of tumor-associated macrophages by antagonizing NF-κB signaling. Oncogene. 34(2). 177–187. 33 indexed citations
15.
Neeße, Albrecht, Anke Hahnenkamp, Heidi Griesmann, et al.. (2012). Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions. Gut. 62(7). 1034–1043. 68 indexed citations
16.
Neeße, Albrecht, Heidi Griesmann, Thomas M. Gress, & Patrick Michl. (2012). Claudin-4 as therapeutic target in cancer. Archives of Biochemistry and Biophysics. 524(1). 64–70. 42 indexed citations
17.
Ripka, S, Jan Riedel, Albrecht Neeße, et al.. (2010). Glutamate Receptor GRIA3—Target of CUX1 and Mediator of Tumor Progression in Pancreatic Cancer. Neoplasia. 12(8). 659–IN6. 37 indexed citations
18.
Beitzinger, Michaela, Lars Hofmann, Rasa Beinoravičiūtė-Kellner, et al.. (2008). p73 poses a barrier to malignant transformation by limiting anchorage‐independent growth. The EMBO Journal. 27(5). 792–803. 44 indexed citations
19.
Griesmann, Heidi, Katharina Schlereth, Michael Krause, Birgit Samans, & Thorsten Stiewe. (2008). p53 and p73 in suppression of Myc‐driven lymphomagenesis. International Journal of Cancer. 124(2). 502–506. 7 indexed citations
20.
Çam, Hakan, Heidi Griesmann, Michaela Beitzinger, et al.. (2006). p53 family members in myogenic differentiation and rhabdomyosarcoma development. Cancer Cell. 10(4). 281–293. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Demirkan Gursel Breakdown of academic impact, for papers by John J. Halliday Breakdown of academic impact, for papers by Nicolas Gengenbacher Breakdown of academic impact, for papers by Véronique Garambois Breakdown of academic impact, for papers by Hideo Takeshima Breakdown of academic impact, for papers by Ivane Abiatari Breakdown of academic impact, for papers by Carl Koschmann Breakdown of academic impact, for papers by Shobha Castelino‐Prabhu Breakdown of academic impact, for papers by Elin Ekström Breakdown of academic impact, for papers by Rana Mhaidly
Rankless by CCL
2026